Detalhe da pesquisa
1.
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022.
Emerg Infect Dis
; 29(5): 1051-1054, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37081594
2.
Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France.
Emerg Infect Dis
; 29(2): 286-293, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36596569
3.
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.
J Viral Hepat
; 30(3): 232-241, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36529681
4.
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
Pharmacoepidemiol Drug Saf
; 32(4): 486-495, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36444965
5.
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Qual Life Res
; 32(12): 3427-3438, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37587323
6.
Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort).
Liver Int
; 42(1): 249-252, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34825765
7.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Liver Int
; 42(1): 38-49, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34520614
8.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35086481
9.
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
J Hepatol
; 74(1): 37-47, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32798585
10.
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.
J Hepatol
; 74(6): 1325-1334, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33503489
11.
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis.
HIV Med
; 22(10): 924-935, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34402547
12.
Effectiveness of direct-acting antivirals for chronic hepatitis C treatment in migrant and non-migrant populations in France.
Liver Int
; 41(10): 2328-2340, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33590608
13.
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
J Hepatol
; 73(5): 1046-1062, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32634548
14.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30765123
15.
Comparing interferon-free with interferon-based regimens in HCV patients: Rogers phenomenon and Simpson's paradox.
J Viral Hepat
; 27(3): 329-332, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31654535
16.
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort).
J Viral Hepat
; 27(12): 1473-1483, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32810343
17.
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort.
J Viral Hepat
; 27(10): 964-973, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32436335
18.
Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
J Hepatol
; 70(5): 831-838, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30879789
19.
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy.
J Viral Hepat
; 26(11): 1276-1283, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31273896
20.
The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C.
J Viral Hepat
; 26(12): 1489-1492, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31386252